Sprintec Kit
Product Images NDC 68788-7429

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sprintec (NDC 68788-7429). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Blister Image (Image 1)

This is a description of a medication called "Sprinte". It is a tablet that contains norgestimate and ethinyl estradiol. The dosage of the medication is 0.250 mg/0.035 mg. The text also includes storage instructions stating that the medication should be stored at a temperature of 20 to 25°C (68 to 77°F). The medication is sold by a company called Aue Bunyes.*

FDA Label Image

Norgestimate Structural Formula (Image 2)

FDA Label Image

Ethinyl Estradiol Structural Formaula (Image 3)

FDA Label Image

Fewer-more Pregnancies Image (Image 4)

This text is a list of different birth control methods, including implants, injections, intrauterine devices, sterilization, birth control pills, skin patch, vaginal ring with hormones, condoms, diaphragm, 'no sex during the most fertile days of the monthly cycle, spermicide, and withdrawal.*

FDA Label Image

Blister Image (Image 5)

This is a prescription drug called Sprintec, which contains norgestimate and ethinyl estradiol. It comes in 0.250mg/0.035mg tablets and should be stored at controlled room temperature of 20-25°C (68-77°F). The text also includes information about where the drug can be purchased but it is not clear due to errors.*

FDA Label Image

Sprintec Tablets 0.250mg/0.035mg (Image 6)

This is information related to Sprintec tablets, which are a generic version of Ortho-Cyclen birth control pills. The federal law prohibits the transfer of these tablets to anyone other than the patient. The package contains 0.250mg/0.035mg strength tablets, and the manufacturer is Teva Pharmaceuticals USA Inc. The lot number, expiration date, and other manufacturing information is also provided on the package. There is a caution notice provided on the top of the package.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.